Bajaj Finserv Healthcare IDCW Payout Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹500

Bajaj Finserv Healthcare IDCW Payout Direct Plan

NAV
₹10.0050
-0.66%
(18 Jul)
AUM
332 Cr
TER
0.67%
Risk
Very High Risk
Insights
Asset Under Management (AUM) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
-5.6%
-5.6%
-6.7%
-6.7%
NA
3Y
+39.1%
+39.1%
+39.6%
+39.6%
NA
5Y
+32.8%
+32.8%
+31.3%
+31.3%
NA
ALL
+12.3%
+12.3%
+17.1%
+17.1%
+0.7%
VOL
20.3%
20.3%
20.3%
20.3%
15.2%
TER
0.8%
0.8%
0.9%
0.9%
0.7%
AUM
₹5,427 Cr
₹5,427 Cr
₹1,439 Cr
₹1,439 Cr
₹332 Cr
INFO
0.60
0.60
0.84
0.84
0.05
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Bajaj Finserv Healthcare IDCW Payout (DP)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Jun
Top holdings
Divi's Laboratories Ltd
8.7%
Sun Pharmaceuticals Industries Ltd
7.5%
Cipla Ltd
6.1%
Apollo Hospitals Enterprise Ltd
6.0%
Glenmark Pharmaceuticals Ltd
3.5%
Biocon Ltd
3.5%
Dr Reddy's Laboratories Ltd
3.5%
Piramal Pharma Ltd
3.3%
Emcure Pharmaceuticals Ltd
3.2%
Abbott India Ltd
3.2%
Top industry exposure
Healthcare
88.8%
Consumer Defensive
6.4%
Basic Materials
1.7%
Financial Services
0.5%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹500
Additional lumpsum
₹100
Portfolio turnover
-
Lock-in period
-
Exit load
• 1% for redemption within 90 days
Fund objective
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Fund manager(s)
Nimesh Chandan
Siddharth Chaudhary
Sorbh Gupta

FAQs